Septerna, Inc. (SEPN) Free Cash Flow
Septerna, Inc. (SEPN) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2022-12-31 | -$24.59M |
| 2023-12-31 | -$41.60M |
| 2024-12-31 | -$69.57M |
| 2025-12-31 | $109.67M |
How SEPN compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| EBS | Emergent BioSolutions Inc. | $156.80M |
| ARRY | Array Technologies Inc. | $79.81M |
| AKBA | Akebia Therapeutics Inc. | $67.70M |
| TGTX | TG Therapeutics Inc. | -$24.99M |
| MYGN | Myriad Genetics Inc. | -$25.60M |
These are five companies in the same sector as SEPN with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Septerna, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("SEPN", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | SEPN | $39.16 | -3.25% | 0.17M |
| 3 | ||||
| 4 | ||||
| 5 |